⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of KBI Biopharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
KBI Biopharma
↗Durham, North Carolina, USA
KBI Biopharma is a global contract development and manufacturing organization (CDMO) that provides fully integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies. The company supports clients from early-stage development through to commercial manufacturing, specializing in mammalian and microbial cell line development, process and analytical development, and formulation.
As a JSR Life Sciences company, KBI Biopharma leverages a global network of facilities across the USA and Europe. They are recognized for their expertise in complex biotherapeutics, including monoclonal antibodies, vaccines, and advanced therapies, focusing on robust, scalable processes that ensure regulatory compliance and efficiency.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1996
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy, Recombinant proteins
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:JSR Corporation
Acquired By:JSR Corporation (JSR Life Sciences) (2013-01-01)
Key Partnerships:Infinimmune (Antibody manufacturing collaboration), JSR Life Sciences (Parent company/Sustainability alignment)
COMPETITION
Position:Leader
Competitors:Lonza, Thermo Fisher Scientific, Catalent, Samsung Biologics
LEADERSHIP
Key Executives:
J.D. Mowery - President & CEO
Sigma Mostafa - Chief Scientific Officer
Peter Carbone - Chief Quality Officer
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with KBI Biopharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.